biopharmaceutical services
|
|
|
|
We know that delivering a biologic to the market can be a very challenging and time sensitive process. Robust safety data, timely reporting, and rigorous attention to quality are critical factors in the successful development of a biologic from preclinical phase to product release. Charles River's global Biopharmaceutical Services (BPS) delivers client-focused solutions to your specific testing and manufacturing requirements for your biologic.
We are one comprehensive source for testing and clinical-scale manufacturing. The assays provided range from cell characterization, process validation studies through to stability and product release testing. Manufacturing services include cell banking, vaccines, fill and finish, and antisera production. Through our global reach, with facilities located in Malvern, PA (USA); Edinburgh, UK; and Ballina, Co. Mayo, Ireland, we provide more flexibility, experience and expertise, from multiple regulatory environments.
|
antisera production, cell banking, cell storage facilities, fill and finish, mammanlian/insect cell banking, microbial cell banking, vaccine manufacturing, biosafety, cell line characterization, custom method development, endotoxin and pyrogenicity, lot and final drug product release, mammalian/insect cell line characterization, microbial cell line characterization, pcr, potency assays, protein and analytical chemistry, process validation for viral clearance, stability testing, safety of vaccines, virology, sterility, biotechnology, drug discovery and development, manufactured products